Globalpharma holds symposia to introduce to GCC markets new product for treatment of gynecological disorders
Globalpharma, Dubai's first pharmaceutical manufacturing company and a subsidiary of Dubai Investments Industries, wholly owned by Dubai Investments has announced that it recently hosted a series of symposia in different emirates in United Arab Emirates to promote the company's first under license product that cures gynecological disorders..
The symposia featured international speaker Dr. Eiko E. Petersen, former Head of the Department of Infectious Diseases in Gynecology and Obstetrics at the Women's Hospital of the University of Freiburg, Germany. Dr. Petersen lectured about infections and other disorders during the symposia, which were each attended by at least 50 leading, potential gynecologists from different areas in the UAE.
"This is another breakthrough for Globalpharma, which will ultimately benefit the quality of healthcare in the UAE. Dr. Petersen brings with him a wealth of knowledge on gynecology that will help Globalpharma underscore the value of this new therapeutic solution in maintaining good health. With its considerable success in Europe and its efficacy proven by many reliable clinical trials, we are confident that the new product will have a strong market impact in the region as people are now becoming increasingly conscious of their personal health and hygiene," said Syed Jamil Akhtar, General Manager, Globalpharma.
The symposia were held at the Al Bustan Rotana Hotel in Dubai, at the Radisson SAS Hotel in Sharjah and at the Inter Continental Hotel in Abu Dhabi from 21st to May 23. Each symposium also featured a top notch gynecologist from the UAE, who also spoke about the subject.
